E. Carmack Holmes is Director at CYTORI THERAPEUTICS, INC. (CYTX). They have made 1 open-market trade across 1 company since 2010, most recently 2014-05-19.
CIK 0001259720
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $9K since 2011, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CYTX | 13,417 | $3K |
Shares reported on the most recent Form 4, priced at the 2014-05-20 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.